Remove market-access aduhelm-and-expensive-failure-launch
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. 2022 R&D Spend: Pfizer’s R&D expenses during 2022 were $11.43 2022 R&D Spend: Pfizer’s R&D expenses during 2022 were $11.43 Pfizer Inc.

Sales 98